Company Filing History:
Years Active: 2003-2024
Title: Juergen Sigg: Innovator in Pharmaceutical Solutions
Introduction
Juergen Sigg is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of high-concentration antibody solutions and syringe technology. With a total of five patents to his name, Sigg's work has had a substantial impact on medical treatments.
Latest Patents
One of Juergen Sigg's latest patents is a protein solution formulation containing a high concentration of an anti-VEGF antibody. This invention provides anti-VEGF antibodies formulated as high-concentration, aqueous pharmaceutical compositions suitable for injection, preferably intravitreal injection. The compositions are designed to deliver a high concentration of the antibody active ingredient to patients while minimizing antibody aggregation and sub-visible particulate matter. The aqueous composition includes an antibody concentration of at least 50 mg/ml, along with a sugar, a buffering agent, and a surfactant. Another significant patent relates to a syringe, specifically a small volume syringe suitable for ophthalmic injections.
Career Highlights
Throughout his career, Juergen Sigg has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharmaceuticals Corporation. His expertise in developing innovative solutions has positioned him as a key figure in the advancement of medical technologies.
Collaborations
Juergen Sigg has collaborated with notable professionals in his field, including Christophe Royer and Andrew Mark Bryant. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
Juergen Sigg's contributions to pharmaceutical innovations, particularly in antibody formulations and syringe technology, highlight his role as a leading inventor in the industry. His work continues to influence medical practices and improve patient care.